These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15968938)

  • 1. Heal the damage: prescription drug consumer advertisements and relative choices.
    Gilhooley M
    J Health Law; 2005; 38(1):1-44. PubMed ID: 15968938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT; Duhamel LM; Dievler A; Price R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer prescription drug advertising.
    Terzian TV
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract]   [Full Text] [Related]  

  • 4. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-to-consumer marketing of prescription drugs: creating consumer demand.
    Hollon MF
    JAMA; 1999 Jan; 281(4):382-4. PubMed ID: 9929096
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The educational potential of direct-to-consumer prescription drug advertising.
    Kaphingst KA; DeJong W
    Health Aff (Millwood); 2004; 23(4):143-50. PubMed ID: 15318574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What kind of patients and physicians value direct-to-consumer advertising of prescription drugs.
    Gönül FF; Carter F; Wind J
    Health Care Manag Sci; 2000 Jun; 3(3):215-26. PubMed ID: 10907324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Morgan S; Mintzes B; Barer M
    J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-consumer advertisements of prescription drugs.
    Council on Ethical and Judicial Affairs of the American Medical Association
    Food Drug Law J; 2000; 55(1):119-24. PubMed ID: 12322719
    [No Abstract]   [Full Text] [Related]  

  • 12. Schroeder Lecture. Worst pills, best pills.
    Wolfe SM
    Health Matrix Clevel; 2006; 16(2):785-96. PubMed ID: 16948255
    [No Abstract]   [Full Text] [Related]  

  • 13. A history of drug advertising: the evolving roles of consumers and consumer protection.
    Donohue J
    Milbank Q; 2006; 84(4):659-99. PubMed ID: 17096638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-the-counter sales of statins and other drugs for asymptomatic conditions.
    Tinetti ME
    N Engl J Med; 2008 Jun; 358(25):2728-32. PubMed ID: 18565867
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers.
    Mello MM; Rosenthal M; Neumann PJ
    JAMA; 2003 Jan 22-29; 289(4):477-81. PubMed ID: 12533128
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of prescription drug promotion: direct-to-consumer advertising.
    Baylor-Henry M; Drezin NA
    Clin Ther; 1998; 20 Suppl C():C86-95. PubMed ID: 9915094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liability for adverse events in direct-to-consumer advertising.
    Shein D
    JAMA; 2003 May; 289(20):2646; author reply 2647. PubMed ID: 12771107
    [No Abstract]   [Full Text] [Related]  

  • 18. Liability for adverse events in direct-to-consumer advertising.
    Evans GW; Friede AI
    JAMA; 2003 May; 289(20):2646-7; author reply 2647. PubMed ID: 12771108
    [No Abstract]   [Full Text] [Related]  

  • 19. MSJAMA: direct-to-consumer advertising of prescription drugs: implications for the patient-physician relationship.
    Kravitz RL
    JAMA; 2000 Nov; 284(17):2244. PubMed ID: 11056603
    [No Abstract]   [Full Text] [Related]  

  • 20. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
    Kraushaar KJ
    Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.